MPWT
NTLA icon

MassMutual Private Wealth & Trust’s Intellia Therapeutics NTLA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.71K Sell
219
-12
-5% -$168 ﹤0.01% 1787
2026
Q1 		$2.96K Buy
231
+11
+5% +$140 ﹤0.01% 1866
2025
Q4 		$1.98K Hold
220
– – ﹤0.01% 1997
2025
Q3 		$3.8K Buy
220
+121
+122% +$1.49K ﹤0.01% 1779
2025
Q2 		$929 Sell
99
-37
-27% -$304 ﹤0.01% 2139
2025
Q1 		$967 Buy
136
+117
+616% +$1.18K ﹤0.01% 2135
2024
Q4 		$222 Sell
19
-13
-41% -$203 ﹤0.01% 2244
2024
Q3 		$658 Sell
32
-10
-24% -$231 ﹤0.01% 1941
2024
Q2 		$940 Sell
42
-57
-58% -$1.36K ﹤0.01% 1826
2024
Q1 		$2.72K Buy
99
+81
+450% +$2.25K ﹤0.01% 1448
2023
Q4 		$549 Sell
18
-65
-78% -$1.87K ﹤0.01% 1799
2023
Q3 		$2.62K Buy
+83
New +$3.22K ﹤0.01% 1427
2022
Q4 		– Sell
-167
Closed -$9K – 1779
2022
Q3 		$9K Sell
167
-437
-72% -$27.1K ﹤0.01% 784
2022
Q2 		$31K Hold
604
– – ﹤0.01% 511
2022
Q1 		$44K Sell
604
-5
-0.8% -$424 ﹤0.01% 479
2021
Q4 		$72K Buy
609
+5
+0.8% +$626 ﹤0.01% 444
2021
Q3 		$81K Hold
604
– – ﹤0.01% 420
2021
Q2 		$98K Hold
604
– – ﹤0.01% 403
2021
Q1 		$48K Hold
604
– – ﹤0.01% 442
2020
Q4 		$33K Buy
+604
New +$21.9K ﹤0.01% 478

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

MassMutual Private Wealth & Trust's NTLA Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Intellia Therapeutics (NTLA) stake by 5.2% in Q2 2026, selling an estimated $168 and leaving 219 shares worth $3.71K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

MassMutual Private Wealth & Trust first reported a position in NTLA in Q4 2020 and has held it in 20 quarters since. The position peaked at $98K in Q2 2021. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • MassMutual Private Wealth & Trust held 219 shares of Intellia Therapeutics worth $3.71K as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 12 Intellia Therapeutics shares in Q2 2026, an estimated $168.
  • Intellia Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1787 holding.
  • MassMutual Private Wealth & Trust first reported a position in Intellia Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • MassMutual Private Wealth & Trust's Intellia Therapeutics position peaked at $98K in Q2 2021.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.